Disinfectants & Antiseptics in Pharmaceutical Industry: Selection, Validation, Rotation Strategy & GMP Compliance Guide (USP 1072 | EU Annex 1 | Audit-Ready 2026)
Disinfectants & Antiseptics in Pharmaceutical Industry: Selection, Validation, Rotation Strategy & GMP Compliance Guide (USP 1072 | EU Annex 1 | Audit-Ready 2026) Advertisement Table of Contents 1. Introduction 2. Scientific Principle of Disinfection 3. Selection Criteria (Problem-Based Approach) 4. Disinfectant Validation Process 5. Rotation Strategy & Resistance Prevention 6. Regulatory Expectations (USP, PDA, EU GMP) 7. Practical Scenarios & Lab Failures 8. Common Audit Observations 9. Frequently Asked Questions 10. Summary & Conclusion 1. Introduction In pharmaceutical manufacturing, contamination control failures are rarely due to lack of cleaning — they occur due to incorrect disinfectant selection, poor validation, improper rotation, or human error. Regulatory agencies expect scientific justification, documented validation, and continuous monitoring. Disinfectants reduce microbial load on inanimate surfaces, while antiseptics a...